Abstract:An evolving paradigm expanding the genetic basis of cancer suggests that tissue-specific developmental programs indelibly imprint restricted repertoires of homeostasis, forming the substrate for lineage-dependent tumor induction by dysregulation of survival pathways. GUCY2C, the intestinal receptor for the paracrine hormones guanylin and uroguanylin whose early loss universally characterizes colorectal transformation, has emerged as a component of homeostatic programs organizing spatiotemporal patterning along the crypt-surface axis, and its dysregulation promotes tumorigenesis through hyperproliferation and genetic instability. Here we identify GUCY2C as a switch for lineage-dependent tumorigenesis whose disruption reprograms survival circuits essential for regenerative homeostasis and universally required for tumorigenesis. Eliminating GUCY2C expression in mice expands proliferating crypts, accelerating the cell cycle by regulating mediators of the G1/S transition, including cyclin D1, pRb, and p27. Further, loss of GUCY2C produces an increase in aerobic glycolysis, reflected by elevated glucose transport and lactate production associated with increased expression of rate-limiting glycolytic proteins universally up-regulated in tumors, including glucose transporter I, hexokinase II, phosphofructokinase, and pyruvate kinase. Conversely, there is a reciprocal reduction in mitochondrial biogenesis and oxidative phosphorylation, reflected by a decrease in mitochondrial genome, proteins, and organelles associated with reduced mitochondrial oxygen consumption, dehydrogenase activity and ATP production, recapitulating the tumor metabolic phenotype. Conversely, GUCY2C signaling restores replicative and metabolic homeostatic circuits in colon cancer cells, recapitulating the phenotype of normal enterocytes. Moreover, oral administration of the proximal downstream mediator of GUCY2C, cyclic GMP, reverses crypt hyperplasia and restores proliferative and metabolic programs in mice deficient in GUCY2C. Coordination of survival circuits by GUCY2C is orchestrated through the oncogene AKT, whose inhibition mimics, and activation eliminates, GUCY2C regulation of proliferation and metabolism. AKT modulation by GUCY2C involves the tumor suppressor PTEN, whose silencing eliminates GUCY2C regulation of AKT, proliferation and metabolism. Thus, disruption of developmentally restricted signaling by GUCY2C, reflecting loss of paracrine hormones, induces maladaptive survival pathways essential for crypt-surface homeostasis whose tissue-specific deregulation contributes to lineage dependency in intestinal tumorigenesis. With the role of guanylin and uroguanylin loss in transformation, the universal compensatory over-expression of GUCY2C by colorectal tumors offers a unique therapeutic opportunity for cancer prevention through oral hormone supplementation. Citation Information: In: Proc Am Assoc Cancer Res; 2009 Apr 18-22; Denver, CO. Philadelphia (PA): AACR; 2009. Abstract nr 4412.

The Linear Ubiquitin-Specific Deubiquitinase Gumby Regulates Angiogenesis.

SCF Slmb E3 ligase-mediated degradation of Expanded is inhibited by the Hippo pathway in Drosophila

OTULIN Allies with LUBAC to Govern Angiogenesis by Editing ALK1 Linear Polyubiquitin.

Bam-Dependent Deubiquitinase Complex Can Disrupt Germ-Line Stem Cell Maintenance By Targeting Cyclin A

The evolutionarily conserved deubiquitinase UBH1/UCH-L1 augments DAF7/TGF-β signaling, inhibits dauer larva formation, and enhances lung tumorigenesis

UBE2G1 governs the destruction of cereblon neomorphic substrates.

Abstract #4412: GUCY2C Establishes Lineage Dependence in Intestinal Tumorigenesis Through AKT

UBE2G1 Governs the Destruction of Cereblon Neomorphic Substrates

Linear polyubiquitylation of Gli protein regulates its protein stability and facilitates tumor growth in colorectal cancer

UbcD1 Regulates Hedgehog Signaling by Directly Modulating Ci Ubiquitination and Processing.

Fine-tuning ALK1 Linear Polyubiquitination to Control Angiogenesis

SMURF1/2 are novel regulators of WNK1 stability

The Deubiquitinating Enzyme UCH37 Interacts with Smads and Regulates TGF-β Signalling

The deubiquitylating enzyme Fat Facets promotes Fat signalling and restricts tissue growth

A TargetedIn VivoRNAi Screen Reveals Deubiquitinases As New Regulators of Notch Signaling

Biallelic Hypomorphic Mutations in a Linear Deubiquitinase Define Otulipenia, an Early-Onset Autoinflammatory Disease.

Hyd/UBR5 defines a tumor suppressor pathway that links Polycomb repressive complex to regulated protein degradation in tissue growth control and tumorigenesis

A Huluwa Phosphorylation Switch Regulates Embryonic Axis Induction.

Independent Mutations In Mouse Vangl2 That Cause Neural Tube Defects In Looptail Mice Impair Interaction With Members Of The Dishevelled Family

DUB-2 Is a Member of a Novel Family of Cytokine-inducible Deubiquitinating Enzymes*

Crumbs Regulates Salvador/Warts/Hippo Signaling in Drosophila via the FERM-Domain Protein Expanded